Toxicometabolomics-Based Cardiotoxicity Evaluation of Thiazolidinedione Exposure in Human-Derived Cardiomyocytes.

Author:

Sultan Abdullah Al1,Rattray Zahra1,Rattray Nicholas J. W.1

Affiliation:

1. University of Strathclyde

Abstract

Abstract Introduction Thiazolidinediones (TZDs), represented by pioglitazone and rosiglitazone, are a class of cost-effective oral antidiabetic agents posing a marginal hypoglycaemia risk. Nevertheless, observations of heart failure have hindered the clinical use of both therapies. Objective Since the mechanism of TZD-induced heart failure remains largely uncharacterised, this study aimed to explore the as-yet-unidentified mechanisms underpinning TZD cardiotoxicity using a toxicometabolomics approach. Methods The present investigation included an untargeted liquid chromatography–mass spectrometry-based toxicometabolomics pipeline, followed by multivariate statistics and pathway analyses to elucidate the mechanism(s)of TZD-induced cardiotoxicity using AC16 human cardiomyocytes as a model, and to identify the prognostic features associated with such effects. Results Acute administration of either TZD agent resulted in a significant modulation in carnitine content, reflecting potential disruption of the mitochondrial carnitine shuttle. Furthermore, perturbations were noted in purine metabolism and amino acid fingerprints, strongly conveying aberrations in cardiac energetics associated with TZD usage. The results also highlighted changes in polyamines (spermine and spermidine) and amino acid levels (L-tyrosine and valine), indicating phenotypic alterations in cardiac tissue (hypertrophy), which represents another characteristic of cardiotoxicity and a potential associated mechanism. In addition, this comprehensive study identified two groupings – (i) valine and creatine, and (ii) L-tryptophan and L-methionine – that were significantly enriched in the above-mentioned mechanisms, emerging as potential fingerprint biomarkers for pioglitazone and rosiglitazone cardiotoxicity, respectively. Conclusion These findings demonstrate the utility of toxicometabolomics in elaborating on mechanisms of drug toxicity and identifying potential biomarkers, thus encouraging its application in the toxicological sciences.

Publisher

Research Square Platform LLC

Reference29 articles.

1. Standards of care in diabetes—2023 abridged for primary care providers;Association AD;Clinical Diabetes,2023

2. An untargeted metabolomics approach to investigate the metabolic modulations of HepG2 cells exposed to low doses of bisphenol A and 17β-estradiol;Cabaton NJ;Frontiers in Endocrinology,2018

3. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management;Chaudhury A;Frontiers in Endocrinology (Lausanne),2017

4. Dexamethasone-induced perturbations in tissue metabolomics revealed by chemical isotope labeling LC-MS analysis;Dahabiyeh LA;Metabolites,2020

5. Pioglitazone: the forgotten, cost-effective cardioprotective drug for type 2 diabetes;DeFronzo RA;Diabetes and Vascular Disease Research,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3